Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy

BACKGROUND: Rifaximin and lactulose are common effective agents for hepatic encephalopathy (HE). Whether a combination of rifaximin and lactulose improves the efficacy and mortality in patients with HE compared with lactulose alone needs to be analyzed. METHODS: A systematic search was performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhida, Chu, Pei, Wang, Wenjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301297/
https://www.ncbi.nlm.nih.gov/pubmed/30587923
http://dx.doi.org/10.2147/DDDT.S172324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301297/
https://www.ncbi.nlm.nih.gov/pubmed/30587923
http://dx.doi.org/10.2147/DDDT.S172324

Ejemplares similares